Skip to main content
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
58.45
-1.50 (-2.50%)
At close: Apr 28, 2026, 4:00 PM EDT
58.22
-0.23 (-0.39%)
Pre-market: Apr 29, 2026, 7:54 AM EDT

Boston Scientific Revenue

Boston Scientific had revenue of $5.20B in the quarter ending March 31, 2026, with 11.58% growth. This brings the company's revenue in the last twelve months to $20.61B, up 17.43% year-over-year. In the year 2025, Boston Scientific had annual revenue of $20.07B with 19.87% growth.

Revenue (ttm)
$20.61B
Revenue Growth
+17.43%
P/S Ratio
4.21
Revenue / Employee
$349,390
Employees
59,000
Market Cap
86.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202520.07B3.33B19.87%
Dec 31, 202416.75B2.51B17.61%
Dec 31, 202314.24B1.56B12.29%
Dec 31, 202212.68B794.00M6.68%
Dec 31, 202111.89B1.98B19.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Abbott Laboratories 45.13B
Medtronic 35.48B
Stryker 25.12B
Koninklijke Philips 20.94B
GE HealthCare Technologies 20.63B
Zimmer Biomet Holdings 8.41B
Edwards Lifesciences 6.30B
Smith & Nephew 6.16B
Revenue Rankings

BSX News

More News